Key facts
- This page summarizes Pascal E. R. Girin's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 May 2024, 09:19.
Pascal E. R. Girin - 14 May 2024 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)
- Reporting relationship
- Director
- Issuer ticker
- CLPT
- Reported as of
- 14 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2024, 09:19:53 UTC
- Prior SEC filing
- 02 Apr 2024
- Next SEC filing
- 17 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard F. Mattern, by Power of Attorney for Pascal E. R. Girin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Pascal E. R. Girin filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 15 May 2024.
Change
- Previous filing in this sequence was filed on 02 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLPT
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +17,153
- Change %
- +31%
- Price
- Shares after
- 72,197
- Date
- 14 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLPT
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -17,153
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,153
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.